NUCALA® Special Drug Use Investigation (EGPA, Long-term)
NCT03557060
·
clinicaltrials.gov ↗
COMPLETED
Status
4115
Enrollment
INDUSTRY
Sponsor class
Conditions
Churg-Strauss Syndrome
Eosinophilic Granulomatosis With Polyangiitis
Interventions
DRUG:
Nucala
Sponsor
GlaxoSmithKline